Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
How Ace Hardware built its employee AI assistant
Ace Hardware executives took a careful approach in designing and implementing its new AI assistant to work throughout the chain.
Marketers at Possible adjust to the realities of AI while trying to stay human
Digiday caught up with a raft of executives from across marketing (Geico and Maybelline), agencies (Mediaplus, CROING), content (1440) and research (Marketcast).
‘Maybe ChatGPT is a different kind of a place’: Why OpenAI is saying no to search budgets — for now
OpenAI is coming for performance budgets — it just isn’t ready yet.